Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate vs Denosumab in Kidney Transplant Recipients
NCT04169698Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Oct 2019
- Primary completion
- May 2021
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of denosumab, alendronate in osteoporosis, osteopenia, sponsored by Ain Shams University. Started Oct 2019; status: completed.
02
Drugs
denosumabalendronate
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT04169698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169698.